Finance

Beta
Lists
BIXT:OTCMKTS
Bioxytran Inc
$0.028
-8.25%
(-0.0025) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIXT...
Open
$0.03
High
$0.03
Low
$0.03
Mkt. cap
3.21M
Avg. vol.
45.23K
Volume
157.08K
52-wk high
$0.12
52-wk low
$0.03
EPS
-$0.03
Beta
4.86
Shares outstanding
114.20M
No. of employees
2
Open
$0.03
High
$0.03
Low
$0.03
Mkt. cap
3.21M
Avg. vol.
45.23K
Volume
157.08K
52-wk high
$0.12
52-wk low
$0.03
EPS
-$0.03
Beta
4.86
Shares outstanding
114.20M
No. of employees
2
News stories
From sources across the web
About Bioxytran Inc
CEO-
Employees2
Founded2008
HeadquartersNeedham, Massachusetts, United States
SectorBiotechnology
Websitebioxytraninc.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
102.50K
-
2.00K
225.48K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
124.55K
496.00K
605.28K
1.71M
Operating expense
226.59K
500.24K
610.23K
1.94M
Total operating expenses
226.59K
500.24K
610.23K
1.94M
Operating income
-226.59K
-500.24K
-610.23K
-1.94M
Other non operating income
307.40K
264.80K
15.85K
-73.14K
EBT including unusual items
35.44K
-282.73K
-522.16K
-2.07M
EBT excluding unusual items
35.44K
-282.73K
-656.02K
-2.07M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-2.97K
-
-
-
Net income
35.44K
-282.73K
-522.16K
-2.07M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-45.38K
-47.28K
-61.64K
-60.69K
Net interest expenses
-45.38K
-47.28K
-61.64K
-60.69K
Depreciation and amortization charges
-
-
-
-
EBITDA
-224.08K
-496.00K
-607.28K
-1.93M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer